Governance Changes

iSpecimen Inc.: Filed an Amended Certificate of Designation for Series C Convertible Non-Voting Preferred Stock that adjusts Conversion Price and Floor Price proportionately upon reverse stock splits or similar transactions (effective 2026-01-16).

“On January 16, 2026, the Company filed an Amended Certificate of Designations, Preferences and Rights of the Series C Convertible Non-Voting Preferred Stock (the “ Amended Certificate of Designation ”) with the Secretary of State of the State of Delaware.”

Livento Group, Inc.: Filed Certificate of Amendment to effect a 1-for-20,000 reverse stock split of Common Stock (effective 2025-05-05).

“On May 5, 2025, the Company filed Certificate of Amendment (the "Amendment") to its Second Amended and Restated Certificate of Incorporation (as amended to date, the "Certificate of Incorporation") with the Secretary of State of the State of Delaware to effect a one-for-twenty (1-for-20,000) reverse stock split (the "Reverse Stock Split") of its Common Stock, which the Company expects will become effective on January 28, 2026”

Ondas Inc.: Amended bylaws to reflect name change to Ondas Inc (effective 2026-01-16).

“Additionally, effective as of January 16, 2026, the Company amended its (i) bylaws, (ii) 2018 Equity Incentive Plan (the “2018 Plan”), (iii) 2021 Stock Incentive Plan, as amended (the “2021 Plan,” together with the 2018 Plan, the “Incentive Plans”), and (iv) other corporate governance documents to reflect the change in its name to “Ondas Inc.””

Ondas Inc.: Name change from Ondas Holdings Inc. to Ondas Inc (effective 2026-01-16).

“On January 15, 2026, Ondas Inc. (previously known as Ondas Holdings Inc.) (the “Company”) filed an amendment to its Amended and Restated Articles of Incorporation with the Nevada Secretary of State to change its name from “Ondas Holdings Inc.” to “Ondas Inc.” (the “Amendment”). The Amendment was effective as of January 16, 2026.”

Sharps Technology Inc.: Board approved and adopted an amended and restated Code Of Business Conduct And Ethics to update governance, ethics, and compliance practices (effective 2026-01-15).

“On January 15, 2026, the Board approved and adopted the amended and restated Code Of Business Conduct And Ethics (the “Code of Ethics”), which governs the conduct of all officers, directors, and employees of the Company and its affiliated entities.”

Sharps Technology Inc.: Board approved and adopted Amended and Restated Bylaws to update procedures and make technical changes, including advance notice requirements and Nevada exclusive forum provision (effective 2026-01-15).

“On January 15, 2026, the board of directors (the “Board”) of Sharps Technology, Inc. (the “Company”) approved and adopted the Amended and Restated Bylaws of the Company (the “Bylaws”) to update certain procedures and make various technical and conforming changes.”

CISO Global, Inc.: Increased authorized shares of common stock from 300,000,000 to 1,300,000,000 (effective 2026-01-12).

“On January 12, 2026, we filed a Certificate of Amendment with the Secretary of State of the State of Delaware to our Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), to increase the number of authorized shares of our common stock, par value $0.00001 per share, from 300,000,000 to 1,300,000,000.”

John Hancock Comvest Private Income Fund: Adopted Second Amended and Restated Bylaws to modify quorum, voting requirements, and indemnification provisions (effective 2026-01-16).

“On January 16, 2026, the Board of Trustees of John Hancock Comvest Private Income Fund (the “Fund”) adopted the Fund’s Second Amended and Restated Bylaws.”

OneIM Acquisition Corp.: On January 13, 2026, the Company filed its amended and restated memorandum and articles of association with the Cayman Islands Registrar of Companies in connection with the Offering (effective 2026-01-13).

“On January 13, 2026, in connection with the Offering, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on January 13, 2026.”

Callaway Golf Co: Amended and restated bylaws to reflect the corporate name change to Callaway Golf Company (effective 2026-01-15).

“The Company also amended and restated its bylaws (the “Amended and Restated Bylaws”) effective January 15, 2026 to reflect the Name Change.”

Callaway Golf Co: Changed corporate name from Topgolf Callaway Brands Corp. to Callaway Golf Company via certificate of amendment to third restated certificate of incorporation, and subsequently filed fourth restated certificate to combine documents (effective 2026-01-15).

“On January 15, 2026, Topgolf Callaway Brands Corp. (the “Company”) changed its corporate name to Callaway Golf Company pursuant to a certificate of amendment to the Company’s third restated certificate of incorporation (the “Charter Amendment”) filed with the Delaware Secretary of State on January 15, 2026 (the “Name Change”).”

DENNY'S Corp: The certificate of incorporation and bylaws were amended and restated in their entirety in connection with the merger.

“Pursuant to the Merger Agreement, at the Effective Time, the Company’s certificate of incorporation and bylaws were amended and restated in their entirety.”

Vistance Networks, Inc.: Amended bylaws to reflect the new corporate name Vistance Networks, Inc (effective 2026-01-14).

“In connection with the name change, the Board amended the Company’s bylaws to reflect the corporate name Vistance Networks, Inc., also effective on January 14, 2026.”

Vistance Networks, Inc.: Amended and restated certificate of incorporation to change corporate name from CommScope Holding Company, Inc. to Vistance Networks, Inc (effective 2026-01-14).

“On January 13, 2026, the Company filed with the Secretary of State of the State of Delaware a Second Amended and Restated Certificate of Incorporation to change the Company’s corporate name from CommScope Holding Company, Inc. to Vistance Networks, Inc., effective January 14, 2026.”

Amcor plc: Amended memorandum of association to effect a 1-for-5 reverse stock split, consolidating ordinary shares, reducing authorized shares, and increasing par value to $0.05 per share for both ordinary and preferred shares (effective 2026-01-14).

“On January 14, 2026, Amcor plc (“Amcor”) filed an amendment to its memorandum of association to effect the 1-for-5 reverse stock split previously approved by Amcor shareholders at its annual general meeting of shareholders held on November 6, 2025.”

Future FinTech Group Inc.: Approved a 1-for-4 reverse stock split of common stock, reducing authorized shares from 600M to 150M (effective 2026-01-08).

“On January 8, 2026, Future FinTech Group Inc. (the “Company”) filed with the Florida Secretary of State’s office Articles of Amendment (the “Amendment”) to amend its Second Amended and Restated Articles of Incorporation, as amended (“Articles of Incorporation”). As a result of the Amendment, the Company has authorized and approved a 1-for-4 reverse stock split of the Company’s authorized shares of common stock from 600,000,000 shares to 150,000,000 shares, accompanied by a corresponding decrease in the Company’s issued and outstanding shares of common stock (the “Reverse Stock Split”). The common stock will continue to be $0.001 par value. The Company will round up the fractional shares that result from the Reverse Stock Split and no fractional shares will be issued in connection with the Reverse Stock Split and no cash or other consideration will be paid in connection with any fractional shares that would otherwise have resulted from the Reverse Stock Split. The current pre-split numb”

Wheeler Real Estate Investment Trust, Inc.: Filed articles of amendment to charter for one-for-three reverse stock split effective January 16, 2026 and par value decrease from $0.03 to $0.01 per share effective same day (effective 2026-01-16).

“On January 14, 2026, in connection with a one-for-three reverse stock split (the “ Reverse Stock Split ”) of the Common Stock of the Company, to be effective on January 16, 2026, the Company filed two Articles of Amendment to its charter with the State Department of Assessments and Taxation of Maryland that provide for: i. a one-for-three Reverse Stock Split of the Common Stock, to be effective at 5:00 p.m. Eastern Time (the “ Effective Time ”) on January 16, 2026 (the “ First Amendment ”); and ii. the par value of the Common Stock to be decreased from $0.03 per share (as a result of the one-for-three Reverse Stock Split) to $0.01 per share, to be effective at 5:01 p.m. Eastern Time on January 16, 2026 (the “ Second Amendment ”).”

BiomX Inc.: Filed Certificate of Designations for Series Y Convertible Preferred Stock, creating a new series of preferred stock with specific rights and preferences (effective 2026-01-13).

“On January 13, 2026, the Company filed a Certificate of Designations of Series Y Convertible Preferred Stock (the “Certificate of Designations”) with the Secretary of State of the State of Delaware”

MARSH & MCLENNAN COMPANIES, INC.: Adopted amended and restated bylaws to update provisions reflecting DGCL amendments, update advance notice requirements, clarify voting standard and chair authority (effective 2026-01-14).

“On and effective January 14, 2026, the Board of Directors of Marsh & McLennan Companies, Inc. (the “Company”) approved amended and restated bylaws of the Company (the “Amended and Restated Bylaws”). Among other things the amendments (i) update and conform various provisions to reflect the latest amendments to the Delaware General Corporation Law (the “DGCL”), including related to the stockholder list and quorum for committee meetings, (ii) update certain procedural and informational requirements under the advance notice provisions related to director nominations and other proposals, including related to the requirement to provide certain disclosures and information to the Company, the number of nominees the stockholder can nominate and reflecting the universal proxy rules under Rule 14a-19, (iii) clarify the voting standard for matters submitted to the stockholders and (iv) clarify the authority of the chair of the meeting of stockholders.”

VitaNova Life Sciences Corp: Increase in authorized shares to 200,000,000 common and 10,000,000 preferred stock, via Certificate of Amendment filed November 12, 2025 (effective 2025-11-12).

“On November 12, 2025, the Company filed a Certificate of Amendment to the Articles of Incorporation (the “ Previous Certificate of Amendment ”), which became effective on that date, to increase the number of authorized shares of Common Stock and to authorize the issuance of blank check preferred stock”

VitaNova Life Sciences Corp: Name change to VitaNova Life Sciences Corporation and 1-for-3 reverse stock split, effected via Certificate of Amendment filed January 9, 2026 (effective 2026-01-09).

“On January 9, 2026, a Certificate of Amendment to the Articles of Incorporation (the “ Certificate of Amendment ”) effecting the Name Change was filed with the Secretary of State of the State of Nevada and became effective on that date.”

GPGI, Inc.: Amendment to Third Amended and Restated Certificate of Amendment to change company name from CompoSecure, Inc. to GPGI, Inc (effective 2026-01-22).

“On January 11, 2026, the Company Board approved a change in the Company’s name from CompoSecure, Inc. to GPGI, Inc., and an amendment to the Company’s Third Amended and Restated Certificate of Amendment to reflect the change in the Company’s name, to be effective on January 22, 2026.”

Lafayette Digital Acquisition Corp. I: Adopted Amended and Restated Memorandum and Articles of Association in connection with the IPO (effective 2026-01-08).

“On January 8, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.”

HENRY SCHEIN INC: Amended and restated By-Laws to eliminate requirement that Board appoint a President and to permit CEO who is not also President or Chairman (effective 2026-01-10).

“On January 10, 2026, upon the recommendation of the Nominating and Governance Committee of the Board, the Board approved an amendment and restatement of the Company’s Fourth Amended and Restated By-Laws (as amended and restated, the “By-Laws”), effective immediately.”

iRhythm Holdings, Inc.: Amendment of iRhythm, Inc.'s charter to add a provision required by DGCL Section 251(g) regarding stockholder approval (effective 2026-01-12).

“iRhythm amended and restated its Amended and Restated Certificate of Incorporation (as so amended and restated, the “iRhythm Amended and Restated Charter”) by filing the iRhythm Amended and Restated Charter as an exhibit to the Certificate of Merger filed with the Secretary of State of the State of Delaware on January 12, 2026 in connection with the Merger (the “Certificate of Merger”), in order to add a provision, which is required by Section 251(g) of the DGCL, that provides that any act or transaction by or involving iRhythm, other than the election or removal of directors, that requires for its adoption under the DGCL or the iRhythm Amended and Restated Charter the approval of the stockholders of iRhythm shall require the approval of the stockholders of iRhythm Holdings by the same vote as is required by the DGCL and/or the iRhythm Amended and Restated Charter.”

iRhythm Holdings, Inc.: Adoption of Amended and Restated Bylaws of iRhythm Holdings, Inc (effective 2026-01-12).

“Upon consummation of the Holding Company Transaction , the Amended and Restated Certificate of Incorporation of iRhythm Holdings (the “Amended and Restated Certificate of Incorporation”) and the Amended and Restated Bylaws of iRhythm Holdings (the “Amended and Restated Bylaws”) are the same as the certificate of incorporation and bylaws of iRhythm in effect immediately prior to consummation of the Holding Company Transaction , respectively, other than changes permitted by Section 251(g) of the DGCL.”

iRhythm Holdings, Inc.: Adoption of Amended and Restated Certificate of Incorporation of iRhythm Holdings, Inc (effective 2026-01-12).

“The Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on January 12, 2026.”

NORTHERN MINERALS & EXPLORATION LTD.: Bylaws amended to allow shareholders holding at least 25% of voting shares to call a special meeting (effective 2026-01-09).

“On January 9, 2026, the Board of Directors of Northern Minerals and Exploration Ltd. approved and adopted Amended and Restated Bylaws, effective immediately. The amendment revised the Company’s bylaws to permit one or more shareholders holding not less than twenty five percent of the Company’s issued and outstanding shares entitled to vote to call a special meeting of shareholders, subject to the notice and procedural requirements set forth in the bylaws.”

National Healthcare Properties, Inc.: Company filed Articles Supplementary to effect declassification of the Board and prohibit election to be subject to MUTA Section 3-803 without stockholder approval (effective 2026-01-12).

“On January 12, 2026, the Company filed one set of Articles Supplementary with the SDAT to document and effect the Declassification Election (the “Declassification Articles Supplementary”), and a separate set of Articles Supplementary to effect the Prohibition (the “Prohibition Articles Supplementary”), in each case effective immediately upon acceptance for record of such filings by the SDAT.”

National Healthcare Properties, Inc.: Board amended and restated bylaws to implement universal proxy rules, enhance stockholder nomination procedures, provide proxy access, and remove director qualification provision (effective 2026-01-09).

“On January 9, 2026, the Board amended and restated the Company’s amended and restated bylaws, effective immediately (as so amended and restated, the “Amended and Restated Bylaws”), to, among other things: • address the “universal proxy rules” adopted by the SEC pursuant to Rule 14a-19”

Metagenomi Therapeutics, Inc.: Amended and restated bylaws solely to reflect the name change (effective 2026-01-12).

“the Company’s Board also amended and restated its Amended and Restated Bylaws (as amended, the “Second Amended and Restated Bylaws”), effective on January 12, 2026, solely to reflect the Name Change.”

Metagenomi Therapeutics, Inc.: Amended certificate of incorporation to change company name from Metagenomi, Inc. to Metagenomi Therapeutics, Inc (effective 2026-01-12).

“filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.”

Definium Therapeutics, Inc.: Changed company name from Mind Medicine (MindMed) Inc. to Definium Therapeutics, Inc. via alteration of Notice of Articles (effective 2026-01-09).

“On January 9, 2026, the Company filed a Notice of Alteration with the Province of British Columbia Registrar of Companies to alter its Notice of Articles to change the Company’s corporate name from “Mind Medicine (MindMed) Inc.” to “Definium Therapeutics, Inc.””

Bakkt, Inc.: Amended and restated By-Laws to reflect the name change to 'Bakkt, Inc.', effective January 22, 2026 (effective 2026-01-22).

“the Board also approved an amendment and restatement of the By-Laws of the Company (the “Amended and Restated By-Laws”). The Amended and Restated By-Laws will be effective as of 12:01 a.m. Eastern Time on January 22, 2026. The changes in the By-Laws solely reflect the Name Change.”

Bakkt, Inc.: Filed Certificate of Amendment to change company name to 'Bakkt, Inc.', effective January 22, 2026 (effective 2026-01-22).

“the Board approved a Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company (the “Certificate of Amendment”) to change the name of the Company to “Bakkt, Inc.” (the “Name Change”). The Name Change and the Certificate of Amendment will be effective as of 12:01 a.m. Eastern Time on January 22, 2026.”

Bakkt, Inc.: Filed Certificate of Elimination to remove all matters related to Series A Non-Voting Convertible Preferred Stock from the Amended and Restated Certificate of Incorporation (effective 2026-01-09).

“the Company filed a Certificate of Elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware on January 9, 2026. Effective upon filing, the Certificate of Elimination eliminated from the Company’s Amended and Restated Certificate of Incorporation all matters set forth in the Certificate of Designations with respect to the Series A Non-Voting Convertible Preferred Stock.”

Wetouch Technology Inc.: Increased authorized shares of common stock from 15,000,000 to 65,000,000 (effective 2026-01-07).

“On January 7, 2026, Wetouch Technology Inc. (the “Company”) filed with the Secretary of State of the State of Nevada an amendment to the Company’s Articles of Incorporation, as amended (the “Amendment”), which became effective on that date. In connection with the Amendment, the Company also filed its Second Amended and Restated Articles of Incorporation (the “Restated AOI”). The Amendment was approved by the Company’s stockholders at the annual meeting held on December 26, 2025, and increased the number of authorized shares of the Company’s common stock from 15,000,000 to 65,000,000.”

BioAtla, Inc.: Filed Certificate of Designation for Series A Junior Preferred Stock (Super-Voting Share) establishing its voting, dividend, liquidation, redemption, and transfer terms (effective 2026-01-09).

“On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.”

Forian Inc.: Company redomiciled from Delaware to Maryland via statutory conversion, with new charter and bylaws (effective 2026-01-09).

“The Redomiciliation was effective at 12:01 a.m. Eastern Time on January 9, 2026”

Ridgepost Capital, Inc.: Adopted Second Amended and Restated Bylaws solely reflecting the name change (effective 2026-02-11).

“The Company’s board of directors also adopted the Second Amended and Restated Bylaws of the Company solely reflecting the name change, effective as of the Effective Date.”

Ridgepost Capital, Inc.: Amended and Restated Certificate of Incorporation to change company name from P10, Inc. to Ridgepost Capital, Inc (effective 2026-02-11).

“On January 12, 2026, P10, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation changing the Company’s name from “P10, Inc.” to “Ridgepost Capital, Inc.”, effective as of February 11, 2026 (the “Effective Date”).”

Direct Digital Holdings, Inc.: Filing of Certificate of Amendment to effect a 55-to-1 reverse stock split of Series A and Series B common stock (effective 2026-01-12).

“On January 9, 2026, Direct Digital Holdings, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Amendment ”) to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 55-to-1 reverse stock split (the “ Reverse Stock Split ”) of the Company’s shares of Series A common stock, $0.001 par value and Series B common stock, $0.001 par value.”

Mobile Global Esports, Inc.: Increased authorized shares of common stock from 100,000,000 to 300,000,000 (effective 2026-01-12).

“On January 12, 2026, Mobile Global Esports Inc. (the “Company”) filed a Certificate of Amendment with the Secretary of State of the State of Delaware to the Company’s Certificate of Incorporation (the “Certificate of Amendment”) to increase the number of authorized shares of the Company’s common stock from 100,000,000 to 300,000,000.”

Aktis Oncology, Inc.: Amended and restated bylaws to establish procedures for stockholder proposals and director nominations, modify indemnification provisions, and conform to amended charter (effective 2026-01-12).

“the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), became effective as of immediately prior to the completion of the IPO on January 12, 2026. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety to, among other things: (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings; (ii) establish procedures relating to the nomination of directors; (iii) modify the indemnification provisions for the Company’s directors and officers, and (iv) conform to the amended provisions of the Amended and Restated Certificate.”

Aktis Oncology, Inc.: Amended and restated certificate of incorporation to authorize additional common/preferred stock, eliminate existing preferred series, change director removal vote threshold, establish classified board, and eliminate stockholder action by written consent (effective 2026-01-12).

“on January 12, 2026, the Company filed its amended and restated certificate of incorporation (the “Amended and Restated Certificate”) with the Secretary of State of the State of Delaware. The Amended and Restated Certificate amends and restates the Company’s existing sixth amended and restated certificate of incorporation, as amended, in its entirety to, among other things: (i) authorize 480,000,000 shares of Common Stock and 10,000,000 shares of Class A common stock, par value $0.0001 per share; (ii) eliminate all references to the previously-existing series of preferred stock; (iii) authorize 10,000,000 shares of undesignated preferred stock that may be issued from time to time by the Company’s board of directors (the “Board”) in one or more series; (iv) require the approval of at least two-thirds of the shares entitled to vote to remove a director for cause; (v) establish a classified Board, as a result of which, the successors to the directors whose terms have expired will be elect”

GeoVax Labs, Inc.: Filed Certificate of Amendment for 1-for-25 reverse stock split (effective 2026-01-09).

“On January 9, 2026, GeoVax Labs, Inc. (the “Company” or “we”) filed a Certificate of Amendment to our Certificate of Incorporation effecting a 1-for-25 reverse stock split”

Anywhere Real Estate Inc.: Amended and restated the Seventh Amended and Restated Bylaws as the Eighth Amended and Restated Bylaws in connection with the Merger.

“Additionally, pursuant to the terms of the Merger Agreement, at the Effective Time, the Company’s Seventh Amended and Restated Bylaws, as in effect immediately prior to the Effective Time, were amended and restated in its entirety as the Eighth Amended and Restated Bylaws of the Company (the “ Bylaws ”).”

Anywhere Real Estate Inc.: Amended and restated the Seventh Amended and Restated Certificate of Incorporation as the Eighth Amended and Restated Certificate of Incorporation in connection with the Merger.

“Pursuant to the terms of the Merger Agreement, at the Effective Time, the Company’s Seventh Amended and Restated Certificate of Incorporation, as in effect immediately prior to the Effective Time, was amended and restated in its entirety as the Eighth Amended and Restated Certificate of Incorporation of the Company (the “ Charter ”).”

City Office REIT, Inc.: Company acquired via merger; no substantive governance amendment described (effective 2026-01-09).

“The information set forth in the Introductory Note and”

LeonaBio, Inc.: Amended and restated bylaws to reflect the name change to LeonaBio, Inc (effective 2026-01-09).

“Additionally, effective January 9, 2026, the Board approved an amendment and restatement of the Company’s bylaws (the “Amended and Restated Bylaws”) to reflect the Name Change.”